共 44 条
- [1] Yuh L.(1994)Population pharmacokinetic/pharmacodynamic methodology and applications: A bibliography Biometrics 50 566-575
- [2] Beal S. L.(1994)Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis J. Pharmacokin. Biopharmaceutics 22 165-177
- [3] Davidian M.(1993)Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis J. Pharmacokin. Biopharm. 21 209-222
- [4] Harrison F.(1996)A population pharmacokinetic model for docetaxel (taxotere): Model building and validation J. Pharmacokin. Biopharm. 24 153-712
- [5] Hestor A.(2000)Haematological toxicity following different dosing schedules of 5-fluorouacil and epirubicin in rats Anticancer Research 20 1519-1525
- [6] Kowalski K.(1991)Application of population analysis to physiological pharmacokinetics J. Pharmacokin. Biopharm. 19 101S-113S
- [7] Vonesh E.(1996)Physiological pharmacokinetic analysis using population modeling and informative prior distributions J. Am. Stat. Assn. 91 1400-1412
- [8] Wolfinger R.(1996)The Bayesian analysis of population pharmacokinetic models J. of the American Statistical Association 91 62-75
- [9] Wade J. R.(1994)Bayesian analysis of linear and nonlinear population models using the Gibbs sampler Appl. Stat. 43 201-222
- [10] Beal S. L.(2001)Assessment of significance Levels for covariate effects in NONMEM J. Pharmacokin. Pharmacodyn. 28 231-252